Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Rumor: The9, Blizzard WoW Talks Fail, Netease to Take Over

Duowan.com, 4/15/09

Rumors are circulating that negotiations regarding the renewal of the operating license for the 3D MMORPG World of Warcraft (WoW) between Chinese online game developer and operator The9 (Nasdaq: NCTY) and Blizzard have collapsed. As a result, Netease (Nasdaq: NTES) has been granted exclusive operating rights to WoW for mainland China. Chinese gaming portal Duowan inquired about the matter with Netease, and the company did not issue a denial. An industry source has indicated that Tencent (0700.HK) also bid for the operating rights to the game. According to one chip manufacturer, Netease recently started procuring large amounts of hardware to prepare for taking over WoW operation.

Another industry source indicated that Netease will purchase WoW player information and data from The9, and will also receive the operating rights to WoW's second expansion pack "Wrath of the Lich King". At the same time, "Wrath of the Lich King" has likely already received operating approval. The9 did not comment on this news.

Keywords: 0700.HK Blizzard expansion pack Internet MMORPG NCTY Netease NTES operating license Tencent The9 WoW Wrath of the Lich King online gaming

Feedback

Please note, all fields are required.
None of your personal information will be shared with third parties.

SendingSending

Disclaimer

The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports